시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 헬스케어용 생성형 AI 시장 보고서(2025년)
Generative AI In Healthcare Global Market Report 2025
상품코드 : 1824673
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,457,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,334,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,211,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

헬스케어용 생성형 AI 시장의 규모는 향후 수년간 비약적인 성장이 예상됩니다. 2029년에는 104억 6,000만 달러로 성장할 전망이며 CAGR은 34.1%로 예상됩니다. 예측기간의 성장은 의료 영상 기술의 발전, AI를 활용한 모니터링 시스템 증가, 세계화의 진전, 환자 증가, 최신 의료 치료의 증가, 가상 환자 시뮬레이션 증가에 기인할 것으로 전망됩니다. 예측기간의 주요 동향으로는 의료 영상 강화, 원격의료 및 원격 모니터링, 강건성과 일반화, 생성형 AI 알고리즘의 진보, 고급 심장 데이터 분석, 의료 데이터 분석, 실시간 건강 모니터링 등이 있습니다.

향후 5년간의 예측 성장률 34.1%는 이 시장의 과거 예측에서 0.5% 소폭 감소한 수치입니다. 이러한 성장세 둔화는 주로 미국과 다른 국가 간의 관세의 영향 때문입니다. 무역 마찰은 캐나다와 핀란드에서 개발된 인공지능(AI) 진단 알고리즘과 클라우드 컴퓨팅 인프라의 가격을 높여 임상 도입 지연과 의료 IT 지출 증가를 초래하여 미국의 디지털 건강 도입 부문에 지장을 초래할 수 있습니다. 또한 상호관세와 무역의 긴장과 한계 증가로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향이 더욱 광범위해질 것으로 예상됩니다.

헬스케어용 생성형 AI 시장의 성장은 향후 맞춤의료에 대한 수요 증가에 의해 견인될 것으로 예측됩니다. 맞춤의료는 정밀의료라고도 불리며 환자 개개인의 유전자와 환경, 생활습관 등의 개인차를 고려하여 치료에 혁명을 가져옵니다. 맞춤의료에 대한 수요의 급증은 유전체학의 진보, 질병 메커니즘의 이해도 강화, 보다 효율적이고 치밀한 치료의 추구 등 다양한 요인에 의해 추진되고 있습니다. 헬스케어용 생성형 AI는 유전자 프로파일과 병력을 포함한 방대한 환자 데이터를 분석하는 알고리즘을 채택하여 개별 환자의 특성과 필요에 맞는 맞춤형 치료의 선택과 예측을 제공합니다. 예를 들어, 2024년 2월 맞춤의료연합(Personalized Medicine Coalition)에 따르면, FDA의 CDER는 2023년 희귀질환 환자를 위한 16개의 새로운 맞춤치료를 승인했으며, 이는 2022년 6건에서 현저하게 증가했습니다. 이들 치료법 중 7가지는 암 치료용이고, 3가지는 다른 여러가지 질병이나 병태에 대응하기 위해 설계되었습니다. 그러므로 맞춤의료에 대한 수요가 증가함에 따라 헬스케어용 생성형 AI 시장의 성장이 뒷받침되고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

CSM
영문 목차

영문목차

Generative AI in healthcare encompasses the utilization of advanced artificial intelligence models specifically tailored to address the distinctive requirements and complexities of medical practice. These models have the capability to generate detailed simulations based on real-world data, enabling researchers and medical professionals to test hypotheses within a safe environment. This technology is leveraged to generate novel insights and data aimed at enhancing patient outcomes, expediting medical research, and improving the delivery of healthcare services.

The primary components of generative AI in healthcare consist of solutions and services. Services refer to intangible, non-physical components of the economy, in contrast to tangible goods that can be physically touched or handled. These encompass various functions including AI-assisted robotic surgery, virtual nursing assistants, support for clinical judgment or diagnosis, assistance with workflow and administrative tasks, and image analysis, all serving diverse applications such as clinical and systems. Generative AI in healthcare caters to a broad spectrum of end-users including hospitals and clinics, clinical research institutions, healthcare organizations, diagnostic centers, among others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The generative AI in healthcare market research report is one of a series of new reports from The Business Research Company that provides generative AI in healthcare market statistics, including the generative AI in healthcare industry global market size, regional shares, competitors with generative AI in healthcare market share, detailed generative AI in healthcare market segments, market trends, and opportunities, and any further data you may need to thrive in the generative AI in healthcare industry. This generative AI in healthcare market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The generative ai in healthcare market size has grown exponentially in recent years. It will grow from $2.36 billion in 2024 to $3.23 billion in 2025 at a compound annual growth rate (CAGR) of 36.8%. The growth in the historic period can be attributed to increased healthcare data analytics, increased demand for personalized medicine, increased demand for AI-enabled healthcare solutions, increased demand for personalized treatment plans, and increased drug discovery and development processes.

The generative ai in healthcare market size is expected to see exponential growth in the next few years. It will grow to $10.46 billion in 2029 at a compound annual growth rate (CAGR) of 34.1%. The growth in the forecast period can be attributed to increasing medical imaging techniques, increasing AI-powered monitoring systems, increasing globalization, increasing patients, increasing modern medical treatments, and increasing virtual patient simulation. Major trends in the forecast period include medical imaging enhancement, telemedicine and remote monitoring, robustness and generalization, advances in generative AI algorithms, advanced cardiac data analysis, healthcare data analytics, and real-time health monitoring.

The forecast of 34.1% growth over the next five years reflects a modest reduction of 0.5% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. digital health adoption by inflating prices of Artificial intelligence(AI)-powered diagnostic algorithms and cloud computing infrastructure developed in Canada and Finland, resulting in delayed clinical implementation and higher health IT expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growth of the generative AI in healthcare market is expected to be driven by the increasing demand for personalized medicine in the future. Personalized medicine, also referred to as precision medicine, revolutionizes medical treatment by considering individual differences in genes, environment, and lifestyle for each patient. This demand surge for personalized medicine is propelled by various factors, including advancements in genomics, a deeper understanding of disease mechanisms, and the quest for more efficient and targeted therapies. Generative AI in healthcare employs algorithms to analyze extensive patient data, encompassing genetic profiles and medical histories, to craft personalized treatment options and predictions tailored to individual patient characteristics and needs. For instance, according to the Personalized Medicine Coalition in February 2024, the FDA's CDER approved 16 new personalized treatments for rare disease patients in 2023, marking a notable increase from 6 approvals in 2022. Among these treatments, seven were tailored for cancer therapy, with an additional three designed for addressing various other diseases and conditions. Hence, the rising demand for personalized medicine is propelling the growth of the generative AI in healthcare market.

Key players in the generative AI in healthcare market are concentrating on establishing strategic partnerships to drive innovation and gain a competitive advantage. These partnerships play a pivotal role in advancing generative AI in healthcare by harnessing the strengths and resources of multiple organizations to develop groundbreaking solutions, enhance clinical workflows' efficiency, and tackle critical healthcare challenges. For example, in June 2023, Google partnered with Mayo Clinic to integrate generative AI into healthcare. This collaboration aims to leverage generative AI's potential to streamline operations, enhance healthcare delivery, and enable real-time personalized interactions by unlocking previously inaccessible information. Initially focusing on Enterprise Search in Gen App Builder, the partnership aims to improve clinical workflows and patient outcomes while ensuring compliance with HIPAA regulations.

In March 2022, Microsoft Corporation acquired Nuance Communications for approximately $19.7 billion. Through this acquisition, Microsoft aims to bolster its presence in the enterprise software market, particularly in healthcare, and advance its cloud computing business. Nuance Communications specializes in providing generative AI in healthcare and is known for its expertise in the field.

Major companies operating in the generative AI in healthcare market report are Alphabet Inc.; Microsoft Corporation; Amazon Web Services Inc.; Johnson & Johnson Services Inc.; Siemens AG; Intel Corporation; IBM Watson Health Corporation; Ernst & Young Global Limited; Oracle Corporation; Nvidia Corporation; Harman International Industries Inc.; Epic Systems Corporation; Persistent Systems Private Limited; Tempus Labs Inc.; Eleks Inc.; NioyaTech LLC; Saxon Global Inc.; Verge Genomics Inc.; PathAI Inc.; BenevolentAI Ltd; Abridge AI Inc.; Absci Corporation; Atomwise Inc.; Syntegra; Insilico Medicine; Neuralink Corporation; DiagnaMed Holdings Corp.

North America was the largest region in the generative AI in healthcare market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the generative AI in healthcare market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the generative AI in healthcare market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The generative AI in healthcare market includes revenues earned by entities by providing services such as drug discovery process, medical imaging, medical research, personalized treatment plans, medical simulations, and detecting billing fraud. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Generative AI In Healthcare Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on generative ai in healthcare market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for generative ai in healthcare ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The generative ai in healthcare market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Generative AI In Healthcare Market Characteristics

3. Generative AI In Healthcare Market Trends And Strategies

4. Generative AI In Healthcare Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Generative AI In Healthcare Growth Analysis And Strategic Analysis Framework

6. Generative AI In Healthcare Market Segmentation

7. Generative AI In Healthcare Market Regional And Country Analysis

8. Asia-Pacific Generative AI In Healthcare Market

9. China Generative AI In Healthcare Market

10. India Generative AI In Healthcare Market

11. Japan Generative AI In Healthcare Market

12. Australia Generative AI In Healthcare Market

13. Indonesia Generative AI In Healthcare Market

14. South Korea Generative AI In Healthcare Market

15. Western Europe Generative AI In Healthcare Market

16. UK Generative AI In Healthcare Market

17. Germany Generative AI In Healthcare Market

18. France Generative AI In Healthcare Market

19. Italy Generative AI In Healthcare Market

20. Spain Generative AI In Healthcare Market

21. Eastern Europe Generative AI In Healthcare Market

22. Russia Generative AI In Healthcare Market

23. North America Generative AI In Healthcare Market

24. USA Generative AI In Healthcare Market

25. Canada Generative AI In Healthcare Market

26. South America Generative AI In Healthcare Market

27. Brazil Generative AI In Healthcare Market

28. Middle East Generative AI In Healthcare Market

29. Africa Generative AI In Healthcare Market

30. Generative AI In Healthcare Market Competitive Landscape And Company Profiles

31. Generative AI In Healthcare Market Other Major And Innovative Companies

32. Global Generative AI In Healthcare Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Generative AI In Healthcare Market

34. Recent Developments In The Generative AI In Healthcare Market

35. Generative AI In Healthcare Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기